Skip to main content
Livermore
Livermore
ZHEN

Dyadic International Inc

DYAI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213809

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Dyadic International Inc changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of DYAI: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders38136−1
Shares5.57M915.0K5.14M+485.3K (+10.4%)
Value$5.24M$860.1K$4.22M−$161.0K (−3.7%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Dyadic International Inc at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to DYAI in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC928,233$761.2K0.00%
Vanguard Fiduciary Trust Co139,478$114.4K0.00%
Susquehanna International Group, LLP25,925$21.3K0.00%
Black Diamond Financial, LLC19,331$15.9K0.00%
Vanguard Global Advisers, LLC7,385$6.06K0.00%

Sold out (6)

Institutions that held Dyadic International Inc at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of DYAI in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
XTX Topco Ltd36,258$34.1K
Traphagen Investment Advisors LLC13,000$12.2K
UBS Group AG11,487$10.8K
Royal Bank of Canada691$1.00K
Bank of America Corp17$16
Citigroup Inc1$1

Not filed for Q1 2026 yet (1)

Institutions that held Dyadic International Inc at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DYAI in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc914,960$860.1K